Comparison of Homologous and Heterologous Booster SARS-CoV-2 Vaccination in Autoimmune Rheumatic and Musculoskeletal Patients
Vaccination against SARS-CoV-2 to prevent COVID-19 is highly recommended for immunocompromised patients with autoimmune rheumatic and musculoskeletal diseases (aiRMDs). Little is known about the effect of booster vaccination or infection followed by previously completed two-dose vaccination in aiRMD...
Elmentve itt :
Szerzők: |
Honfi Dániel György Gémes Nikolett Szabó Enikő Neuperger Patrícia Balog József Ágoston Nagy Lajos I. Toldi Gergely Puskás László G. Szebeni Gábor Balog Attila |
---|---|
Dokumentumtípus: | Cikk |
Megjelent: |
2022
|
Sorozat: | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
23 No. 19 |
Tárgyszavak: | |
doi: | 10.3390/ijms231911411 |
mtmt: | 33115577 |
Online Access: | http://publicatio.bibl.u-szeged.hu/25233 |
Hasonló tételek
-
Humoral and cellular immunogenicity and safety of five different SARS-CoV-2 vaccines in patients with autoimmune rheumatic and musculoskeletal diseases in remission or with low disease activity and in healthy controls a single center study /
Szerző: Szebeni Gábor, et al.
Megjelent: (2022) -
Delay in booster schedule as a control parameter in vaccination dynamics
Szerző: Wang Zhen, et al.
Megjelent: (2019) -
Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2
Szerző: Szabó Enikő, et al.
Megjelent: (2023) -
How the interval between primary and booster vaccination affects long-term disease dynamics
Szerző: Shoukat Affan, et al.
Megjelent: (2017) -
SARS-CoV-2 vírusfertőzéshez társuló bőrtünetek
Szerző: Rózsa Petra, et al.
Megjelent: (2021)